The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family
- PMID: 9111055
- DOI: 10.1074/jbc.272.17.11439
The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family
Abstract
A 60-kDa protein that undergoes rapid tyrosine phosphorylation in response to insulin and then binds phosphatidylinositol 3-kinase has been previously described in adipocytes and hepatoma cells. We have isolated this protein, referred to as pp60, from rat adipocytes, obtained the sequences of tryptic peptides, and cloned its cDNA. The predicted amino acid sequence of pp60 reveals that it contains an N-terminal pleckstrin homology domain, followed by a phosphotyrosine binding domain, followed by a group of likely tyrosine phosphorylation sites, four of which are in the YXXM motif that binds to the SH2 domains of phosphatidylinositol 3-kinase. The overall architecture of pp60 is thus the same as that of insulin receptor substrates 1 and 2 (IRS-1 and IRS-2), and furthermore both the pleckstrin homology and phosphotyrosine binding domains are highly homologous (about 50% identical amino acids) to these domains in both IRS-1 and IRS-2. Thus, pp60 is a new member of the IRS family, which we have designated IRS-3.
Similar articles
-
A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family.J Biol Chem. 1997 Aug 22;272(34):21403-7. doi: 10.1074/jbc.272.34.21403. J Biol Chem. 1997. PMID: 9261155
-
A novel insulin receptor substrate protein, xIRS-u, potentiates insulin signaling: functional importance of its pleckstrin homology domain.Mol Endocrinol. 1998 Aug;12(8):1086-98. doi: 10.1210/mend.12.8.0147. Mol Endocrinol. 1998. PMID: 9717835
-
The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells.Biochemistry. 1997 Jul 8;36(27):8304-10. doi: 10.1021/bi9630974. Biochemistry. 1997. PMID: 9204876
-
Insulin and IGF-I signaling through the insulin receptor substrate 1.Mol Reprod Dev. 1993 Aug;35(4):346-51; discussion 351-2. doi: 10.1002/mrd.1080350405. Mol Reprod Dev. 1993. PMID: 8398112 Review.
-
The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains.Diabetes. 1993 May;42(5):643-50. doi: 10.2337/diab.42.5.643. Diabetes. 1993. PMID: 8387037 Review.
Cited by
-
Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance.Int J Mol Sci. 2023 Oct 9;24(19):15006. doi: 10.3390/ijms241915006. Int J Mol Sci. 2023. PMID: 37834454 Free PMC article. Review.
-
The Insulin-like Growth Factor Signaling Pathway in Breast Cancer: An Elusive Therapeutic Target.Life (Basel). 2022 Nov 29;12(12):1992. doi: 10.3390/life12121992. Life (Basel). 2022. PMID: 36556357 Free PMC article. Review.
-
Diversity of insulin and IGF signaling in breast cancer: Implications for therapy.Mol Cell Endocrinol. 2021 May 1;527:111213. doi: 10.1016/j.mce.2021.111213. Epub 2021 Feb 17. Mol Cell Endocrinol. 2021. PMID: 33607269 Free PMC article. Review.
-
Insulin signaling in health and disease.J Clin Invest. 2021 Jan 4;131(1):e142241. doi: 10.1172/JCI142241. J Clin Invest. 2021. PMID: 33393497 Free PMC article. Review.
-
IRS2 depletion inhibits cell proliferation and decreases hormone secretion in mouse granulosa cells.J Reprod Dev. 2018 Oct 12;64(5):409-416. doi: 10.1262/jrd.2018-055. Epub 2018 Jul 12. J Reprod Dev. 2018. PMID: 29998910 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
